← Leaderboards
Laura J White
University Of North Carolina Chapel Hill
$5,803,604
Attributed
$5,803,604
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–12$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$5,803,604 · 3
By mechanism
U01$5,118,104 · 1
R21$577,138 · 1
F32$108,362 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Robert E. Johnston$11,943,669
- Ralph S Baric$89,182,261
- William B Klimstra$13,808,129
- Mark T Heise$26,876,746
- Jian None Liu$13,658,713
Others in their field
Top investigators on “Venezuelan Equine Encephalitis Virus”
- Jonathan Smith · Alphavax Human Vaccines, Inc.$18,809,530
- Michael S. Diamond · University Of Pittsburgh At Pittsburgh$18,686,177
- Daniel N Streblow · Oregon Health And Science University$16,685,383
- Colleen B Jonsson · University Of Tennessee Health Sci Ctr$13,559,793
- Scott C Weaver · University Of Texas Medical Br Galveston$12,687,168
- Peter F Wright · Vanderbilt University$12,074,176
Research focus
Venezuelan Equine Encephalitis VirusFailure (Biologic Function)Chimera OrganismAnimal ModelE ProteinFaceAttenuatedEffectivenessAntibody FormationBaseAlphavirusBypassAreaExtracellularEquilibriumComplexAttenuated Live Virus VaccineAntibodiesDengueDengue Hemorrhagic FeverDengue Shock SyndromeDesignAntigensEvaluation
Grant awards (10)
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons$1,070,488
U01 · FY2012 · AI · contact PI
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons$1,379,658
U01 · FY2011 · AI · contact PI
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons$933,677
U01 · FY2010 · AI · contact PI
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons$870,945
U01 · FY2009 · AI · contact PI
A Tetravalent Dengue Vaccine Based on Alphavirus Replicons$863,336
U01 · FY2008 · AI · contact PI
A VEE Replicon-Based Vaccine for Dengue Virus$285,138
R21 · FY2006 · AI · contact PI
A VEE Replicon-Based Vaccine for Dengue Virus$292,000
R21 · FY2005 · AI
Mechanism of VEE Attenuation$18,218
F32 · FY2003 · AI
Mechanism of VEE Attenuation$48,148
F32 · FY2002 · AI
Mechanism of VEE Attenuation$41,996
F32 · FY2001 · AI